Results

Total Results: 59 records

Showing results for "increased".

  1. cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin%20and%20SSRIs%20Graph%20V.%205.pdf
    May 18, 2020 - Warfarin Type of Antidepressant Assess risk and take action if necessary Increased … GI and non-GI bleeding risk is possible Assess risk and take action if necessary Increased GI … and non-GI bleeding risk is possible No special precautions Increased bleeding risk unlikely … No Yes Use only if benefit outweighs risk Increased GI and non-GI bleeding risk is likely
  2. cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin%20and%20NSAIDs%20V.8.pdf
    September 08, 2020 - And Yes No Assess risk and take action if necessary Possible increased risk of bleeding Is patient … Yes Start patient on proton pump inhibitor Assess risk and take action if necessary Possible increased … risk of bleeding No Use NSAIDS only if benefit outweighs risk Increased bleeding risk likely
  3. cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docx
    August 29, 2020 - Warfarin – Antidepressants rule: · Recommendation: Use only if benefit outweighs risk · Rationale: Increased … Tablet Mirtazapine 45 MG Disintegrating Oral Tablet N/A Assess risk and take action if necessary Increased … 10 MG Oral Tablet Escitalopram 20 MG Oral Tablet None Assess risk and take action if necessary Increased … 10 MG Oral Tablet Escitalopram 20 MG Oral Tablet None Assess risk and take action if necessary Increased … Tablet Systemic Corticosteroid = Prednisone 5 MG Oral Tablet Use only if benefit outweighs risk Increased
  4. cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docx
    November 11, 2019 - Omeprazole 40 MG Delayed Release Oral Capsule Assess risk and take action if necessary Possible increased … MG Oral Tablet Sulindac 200 MG Oral Tablet N/A Assess risk and take action if necessary Possible increased … MG Oral Tablet Sulindac 200 MG Oral Tablet N/A Assess risk and take action if necessary Possible increased … Ketorolac Tromethamine 10 MG Oral Tablet N/A Assess risk and take action if necessary Possible increased … Ketorolac Tromethamine 10 MG Oral Tablet N/A Assess risk and take action if necessary Possible increased
  5. cds.ahrq.gov/sites/default/files/cds/artifact/106/HWI_2017.pptx
    January 01, 2017 - Appropriate lipid screening orders increased from 43% to 56% among overweight and obese patients. … Discussion Financial incentives and automation of weight status documentation immediately preceded increased
  6. cds.ahrq.gov/sites/default/files/cds/artifact/logic/2024-02/Wernli%20Recommendations_1.txt
    January 01, 2024 - Breast MRI results in increased biopsy and subsequent cancer detection rate relative to mammography alone
  7. cds.ahrq.gov/sites/default/files/cds/artifact/106/Poster_AAPNCE_10.26.15.pptx
    January 01, 1970 - Variations in care can result in increased healthcare cost without increased quality of patient care.
  8. cds.ahrq.gov/sites/default/files/cds/artifact/632326/Flowchart_Wernli_new.pdf
    April 03, 2024 - Breast MRI results in increased biopsy and subsequent cancer detec2on rate rela2ve to mammography
  9. cds.ahrq.gov/sites/default/files/cds/artifact/136331/Bisphosphonates%20Patient%20Handout.pdf
    July 18, 2023 - osteopenia or osteoporosis, which are conditions associated with thin or fragile bones that are at increased
  10. cds.ahrq.gov/sites/default/files/cds/artifact/66551/Bisphosphonates%20Patient%20Handout.pdf
    July 18, 2023 - osteopenia or osteoporosis, which are conditions associated with thin or fragile bones that are at increased
  11. cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
    October 01, 2017 - of CVD and CRC in adults aged 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased … Persons who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and … Defer the threshold values for lab tests that indicate increased bleeding risks, such as INR and platelet … Persons who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and … Consider completeness Lab values to represent increased risk of bleeding as an Exclusion Usually lab
  12. cds.ahrq.gov/sites/default/files/workgroups/34806/CDS_Connect_WG_October_2021_Summary.pdf
    January 01, 2021 - would enable users to locate and understand the contents of artifacts, which in turn could lead to increased
  13. cds.ahrq.gov/sites/default/files/workgroups/58631/CDS_Connect_WG_February_2022_Summary.pdf
    January 01, 2022 - The feasibility pilot also conducted interviews with seven patients, all of whom reported increased … is allowing providers to see more patients, both by the convenience of remote consultation and in increased
  14. cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
    January 01, 2024 - of CVD in adults aged 40 to 59 years who have a 10 percent or greater 10-year CVD risk, are not at increased … Persons who are not at increased risk for bleeding and are willing to take low-dose aspirin daily for … any dose) OR ordered for or receiving palliative care 14 OR aspirin allergy OR evidence of increased … full recommendation statements (2016 and 2022 together) named the following conditions as carrying an increased … 18 Decision Category Concept Rationale Consider completeness Lab values to represent increased
  15. cds.ahrq.gov/cdsconnect/artifact/primary-care-management-guidance-fall-risk-increasing-drugs
    June 08, 2022 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  16. cds.ahrq.gov/sites/default/files/workgroups/28166/CDS_Connect_WG_Slides_August%202021.pdf
    August 01, 2021 - CEDAR is intended to increase the FAIRness of the PCOR findings in AHRQ repositories • To demonstrate increased
  17. cds.ahrq.gov/taxonomy/term/11091
    May 31, 2022 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  18. cds.ahrq.gov/sites/default/files/CDS_Connect_2024_Final_Report.pdf
    January 01, 2024 - CDS Connect: Final Report 2024 CDS Connect: Final Report 2024 CDS Connect Clinical Decision Support (CDS) Connect is a freely available, web-based platform that enable…
  19. cds.ahrq.gov/sites/default/files/workgroups/1266/CDS_Connect_April2021_WG_Meeting_%20Summary.pdf
    April 15, 2021 - CDS Connect Work Group Meeting Summary 4-15-2021 CDS (Clinical Decision Support) Connect Work Group Meeting Summary April 15, 2021 3:00 – 4:00 pm ET Attendees: 44 people (41 attendees + 3 call-ins) Organization Attendee Names AHRQ Members Steve Bernstein, Roland Gamache, Ed Lomotan, Mary Nix, Mario …
  20. cds.ahrq.gov/sites/default/files/workgroups/34806/CDS_Connect_WG_October_2021_Presentation.pdf
    January 01, 2021 - October 2021 CDS Connect Work Group Call October 2021 CDS Connect Work Group Call Agenda Schedule Topic 3:00 - 3:02 Roll Call, Michelle Lenox (MITRE) 3:02 - 3:05 Review of the Agenda, Maria Michaels (CDC) 3:05 - 3:50 Share and Discuss CDS Connect Priorities through September 2022, Lacy Fabian (MITRE) 3:50 - …

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: